ATC code N02
ATC code N02 Analgesics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup N02 is part of the anatomical group N Nervous system.[4]
| ATC code N: Nervous system |
|---|
|
| ATCvet only |
|
| Other ATC codes |
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QN02.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
N02A Opioids
N02AA Natural opium alkaloids
- N02AA01 Morphine
- N02AA02 Opium
- N02AA03 Hydromorphone
- N02AA04 Nicomorphine
- N02AA05 Oxycodone
- N02AA08 Dihydrocodeine
- N02AA10 Papaveretum
- N02AA11 Oxymorphone
- N02AA51 Morphine, combinations
- N02AA53 Hydromorphone and naloxone
- N02AA55 Oxycodone and naloxone
- N02AA56 Oxycodone and naltrexone
- N02AA58 Dihydrocodeine, combinations
- N02AA59 Codeine, combinations excluding psycholeptics
- N02AA79 Codeine, combinations with psycholeptics
N02AB Phenylpiperidine derivatives
- N02AB01 Ketobemidone
- N02AB02 Pethidine
- N02AB03 Fentanyl
- N02AB52 Pethidine, combinations excluding psycholeptics
- QN02AB53 Fentanyl, combinations excluding psycholeptics
- N02AB72 Pethidine, combinations with psycholeptics
- QN02AB73 Fentanyl, combinations with psycholeptics
N02AC Diphenylpropylamine derivatives
- N02AC01 Dextromoramide
- N02AC03 Piritramide
- N02AC04 Dextropropoxyphene
- N02AC05 Bezitramide
- N02AC52 Methadone, combinations excluding psycholeptics
- N02AC54 Dextropropoxyphene, combinations excluding psycholeptics
- N02AC74 Dextropropoxyphene, combinations with psycholeptics
- QN02AC90 Methadone
N02AD Benzomorphan derivatives
- N02AD01 Pentazocine
- N02AD02 Phenazocine
N02AE Oripavine derivatives
- N02AE01 Buprenorphine
- QN02AE90 Etorphine
- QN02AE99 Oripavine derivatives, combinations
N02AF Morphinan derivatives
- N02AF01 Butorphanol
- N02AF02 Nalbuphine
N02AG Opioids in combination with antispasmodics
- N02AG01 Morphine and antispasmodics
- N02AG02 Ketobemidone and antispasmodics
- N02AG03 Pethidine and antispasmodics
- N02AG04 Hydromorphone and antispasmodics
N02AJ Opioids in combination with non-opioid analgesics
- N02AJ01 Dihydrocodeine and paracetamol
- N02AJ02 Dihydrocodeine and acetylsalicylic acid
- N02AJ03 Dihydrocodeine and other non-opioid analgesics
- N02AJ06 Codeine and paracetamol
- N02AJ07 Codeine and acetylsalicylic acid
- N02AJ08 Codeine and ibuprofen
- N02AJ09 Codeine and other non-opioid analgesics
- N02AJ13 Tramadol and paracetamol
- N02AJ14 Tramadol and dexketoprofen
- N02AJ15 Tramadol and other non-opioid analgesics
- N02AJ16 Tramadol and celecoxib
- N02AJ17 Oxycodone and paracetamol
- N02AJ18 Oxycodone and acetylsalicylic acid
- N02AJ19 Oxycodone and ibuprofen
N02AX Other opioids
- N02AX01 Tilidine
- N02AX02 Tramadol
- N02AX03 Dezocine
- N02AX05 Meptazinol
- N02AX06 Tapentadol
- N02AX07 Oliceridine
- N02AX51 Tilidine and naloxone
N02B Other analgesics and antipyretics
N02BA Salicylic acid and derivatives
- N02BA01 Acetylsalicylic acid
- N02BA02 Aloxiprin
- N02BA03 Choline salicylate
- N02BA04 Sodium salicylate
- N02BA05 Salicylamide
- N02BA06 Salsalate
- N02BA07 Ethenzamide
- N02BA08 Morpholine salicylate
- N02BA09 Dipyrocetyl
- N02BA10 Benorilate
- N02BA11 Diflunisal
- N02BA12 Potassium salicylate
- N02BA14 Guacetisal
- N02BA15 Carbasalate calcium
- N02BA16 Imidazole salicylate
- N02BA51 Acetylsalicylic acid, combinations excluding psycholeptics
- N02BA55 Salicylamide, combinations excluding psycholeptics
- N02BA57 Ethenzamide, combinations excluding psycholeptics
- N02BA59 Dipyrocetyl, combinations excluding psycholeptics
- N02BA65 Carbasalate calcium combinations excluding psycholeptics
- N02BA71 Acetylsalicylic acid, combinations with psycholeptics
- N02BA75 Salicylamide, combinations with psycholeptics
- N02BA77 Ethenzamide, combinations with psycholeptics
- N02BA79 Dipyrocetyl, combinations with psycholeptics
N02BB Pyrazolones
- N02BB01 Phenazone
- N02BB02 Metamizole
- N02BB03 Aminophenazone
- N02BB04 Propyphenazone
- N02BB05 Nifenazone
- N02BB51 Phenazone, combinations excluding psycholeptics
- N02BB52 Metamizole sodium, combinations excluding psycholeptics
- N02BB53 Aminophenazone, combinations excluding psycholeptics
- N02BB54 Propyphenazone, combinations excluding psycholeptics
- N02BB71 Phenazone, combinations with psycholeptics
- N02BB72 Metamizole sodium, combinations with psycholeptics
- N02BB73 Aminophenazone, combinations with psycholeptics
- N02BB74 Propyphenazone, combinations with psycholeptics
N02BE Anilides
- N02BE01 Paracetamol
- N02BE03 Phenacetin
- N02BE04 Bucetin
- N02BE05 Propacetamol
- N02BE51 Paracetamol, combinations excluding psycholeptics
- N02BE53 Phenacetin, combinations excluding psycholeptics
- N02BE54 Bucetin, combinations excluding psycholeptics
- N02BE71 Paracetamol, combinations with psycholeptics
- N02BE73 Phenacetin, combinations with psycholeptics
- N02BE74 Bucetin, combinations with psycholeptics
N02BF Gabapentinoids
- N02BF01 Gabapentin
- N02BF02 Pregabalin
- N02BF03 Mirogabalin
N02BG Other analgesics and antipyretics
- N02BG02 Rimazolium
- N02BG03 Glafenine
- N02BG04 Floctafenine
- N02BG05 Viminol
- N02BG06 Nefopam
- N02BG07 Flupirtine
- N02BG08 Ziconotide
- N02BG09 Methoxyflurane
- N02BG10 Cannabinoids (includes nabiximols)
- N02BG12 Tanezumab
- QN02BG90 Frunevetmab
- QN02BG91 Bedinvetmab
N02C Antimigraine preparations
N02CA Ergot alkaloids
- N02CA01 Dihydroergotamine
- N02CA02 Ergotamine
- N02CA04 Methysergide
- N02CA07 Lisuride
- N02CA51 Dihydroergotamine, combinations
- N02CA52 Ergotamine, combinations excluding psycholeptics
- N02CA72 Ergotamine, combinations with psycholeptics
N02CB Corticosteroid derivatives
- N02CB01 Flumedroxone
N02CC Selective serotonin (5-HT1) agonists
- N02CC01 Sumatriptan
- N02CC02 Naratriptan
- N02CC03 Zolmitriptan
- N02CC04 Rizatriptan
- N02CC05 Almotriptan
- N02CC06 Eletriptan
- N02CC07 Frovatriptan
- N02CC08 Lasmiditan
N02CD Calcitonin gene-related peptide (CGRP) antagonists
- N02CD01 Erenumab
- N02CD02 Galcanezumab
- N02CD03 Fremanezumab
- N02CD04 Ubrogepant
- N02CD05 Eptinezumab
- N02CD06 Rimegepant
- N02CD07 Atogepant
N02CX Other antimigraine preparations
- N02CX01 Pizotifen
- N02CX02 Clonidine
- N02CX03 Iprazochrome
- N02CX05 Dimetotiazine
- N02CX06 Oxetorone
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code N02". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QN02". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.